AnalystsYun ZhongYun Zhong's Stock Forecasts
AnalystsYun Zhong
Sectors:
Industries:
Analyst Ranking
Bottom 4%
#5152 out of 5342 analysts
Average Return
-10.28%
Win Rate
39%23 out of 59
Risk vs Reward
Poor
Good
Yun Zhong's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moonlake ImmunotherapeuticsMLTX | +157.18% | $7.17 | $18.44 | 2025-09-30 - 2026-07-31 | Buy |
Camp4 Therapeutics CorpCAMP | +106.03% | $1.99 | $4.10 | 2025-05-27 - 2026-05-26 | Buy |
Protagonist Therapeutics IncPTGX | +102.48% | $48.88 | $98.97 | 2025-03-28 - 2026-03-27 | Buy |
Opus Genetics IncIRD | +87.37% | $1.98 | $3.71 | 2025-10-29 - 2026-07-31 | Buy |
Tectonic Therapeutic IncTECX | +77.07% | $9.42 | $16.68 | 2022-12-08 - 2023-12-07 | Strong Buy |
Yun Zhong Analyst Color
Get additional color on Yun Zhong's coverage of popular stocks
Yun Zhong's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Wave Life Sciences LtdWVE | 5 | Buy | $12.00 | +117.79% | Maintains | a day ago |
Benitec Biopharma IncBNTC | 1 | Buy | $16.00 | +36.64% | Initiates Coverage On | 4 days ago |
Rezolute IncRZLT | 4 | Buy | $6.00 | +27.12% | Maintains | 2 months ago |
Kalaris Therapeutics IncKLRS | 1 | Buy | $17.00 | +384.33% | Initiates Coverage On | 3 months ago |
Cg Oncology IncCGON | 1 | Buy | $80.00 | +12.38% | Maintains | 3 months ago |
Protagonist Therapeutics IncPTGX | 4 | Buy | $118.00 | -13.64% | Maintains | 3 months ago |
Passage Bio IncPASG | 4 | Hold | $8.00 | +78.97% | Downgrades | 3 months ago |
Ascendis Pharma AASND | 5 | Buy | $273.00 | +11.93% | Reiterates | 4 months ago |
Opus Genetics IncIRD | 2 | Buy | $10.00 | +169.54% | Maintains | 5 months ago |
Mannkind CorpMNKD | 1 | Buy | $8.00 | +104.60% | Maintains | 5 months ago |
Sarepta Therapeutics IncSRPT | 7 | Buy | $34.00 | +128.80% | Maintains | 6 months ago |
Keros Therapeutics IncKROS | 3 | Hold | $16.00 | +58.89% | Maintains | 9 months ago |
Moonlake ImmunotherapeuticsMLTX | 2 | Buy | $18.00 | -2.39% | Maintains | 10 months ago |
Sagimet Biosciences IncSGMT | 1 | Buy | $28.00 | +293.81% | Initiates Coverage On | a year ago |
Voyager Therapeutics IncVYGR | 1 | Buy | $8.00 | +164.03% | Maintains | a year ago |
Camp4 Therapeutics CorpCAMP | 1 | Buy | $8.00 | N/A | Initiates Coverage On | a year ago |
Rocket Pharmaceuticals IncRCKT | 2 | Buy | $32.00 | N/A | Reiterates | a year ago |
Anavex Life Sciences CorpAVXL | 2 | Strong Buy | $28.00 | N/A | Maintains | 3 years ago |
Amicus Therapeutics IncFOLD | 1 | Strong Buy | $16.00 | N/A | Maintains | 4 years ago |
Dianthus Therapeutics IncDNTH | 3 | Strong Buy | $3.00 | N/A | Maintains | 4 years ago |
Tectonic Therapeutic IncTECX | 2 | Strong Buy | $48.00 | N/A | Upgrades | 4 years ago |
Applied Genetic Technologies CorpAGTC | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Renovacor IncRCOR | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Freeline Therapeutics Holdings PLCFRLN | 2 | Strong Buy | $75.00 | N/A | Maintains | 4 years ago |
Lenz Therapeutics IncLENZ | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 4 years ago |
Bluebird Bio IncBLUE | 2 | Hold | $700.00 | N/A | Downgrades | 5 years ago |
Uniqure NvQURE | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | 5 years ago |
Cartesian Therapeutics IncRNAC | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 5 years ago |
Sio Gene Therapies IncSIOX | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 5 years ago |
Taysha Gene Therapies IncTSHA | 1 | Strong Buy | $44.00 | N/A | Initiates Coverage On | 5 years ago |
Mereo Biopharma Group PLCMREO | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 5 years ago |
Nightstar Therapeutics PLCNITE1 | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.